-
Most Recent
Search Results
240 results for CEL
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
11 Biotechnology Stocks to Sell Now
This week, the overall grades of 11 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
10 Biotechnology Stocks to Sell Now
The ratings of 10 biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?
A new deal offers a lifeline for TCRR stock and a compatible investment for Adaptimmune. Both companies are targeting solid cancer tumors.
11 Biotechnology Stocks to Sell Now
This week, the ratings of 11 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
11 Biotechnology Stocks to Sell Now
This week, the ratings of 11 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
12 Biotechnology Stocks to Sell Now
This week, the overall grades of 12 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
11 Biotechnology Stocks to Sell Now
This week, the overall grades of 11 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
Top Telecom Stock Performers in April – T, VZ, S, LEAP, PCS
Telecom stocks as a group slightly outperformed the market in April. Diversified telecommunications blue chips like AT&T (T) and Verizon (VZ) didn’t have much to…
AI’s Wildest Dreams Are in Space – but Its Richest Opportunities Aren’t
There’s no denying the excitement around AI – it’s even reaching beyond Earth, with talk of space-based data centers and orbital computing. But while Big…
Cardano Price Predictions: Where Will ADA Go Amid a Nasty Crypto Crash?
Cardano (ADA) price predictions are worth checking in on Tuesday as traders wonder where the token will head after the crypto crash.
13 Biotechnology Stocks to Sell Now
This week, the ratings of 13 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
What the Bleep is Going On With Ethereum (ETH-USD)…and Bitcoin (BTC-USD)
Liquidity issues spilled over from Lido (LDO-USD)…to Celsius Network (CEL-USD)…to everything else. Here’s a look at the top stories and what to make of the…
7 Very Oversold Nasdaq Stocks to Buy Right Now
The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq stocks poised to rebound.
Crypto Exchanges in Trouble: Exchanges Halting Withdrawals Amid Market Collapse
There are lots of crypto exchanges in trouble during the slow burn of the market, as evidenced by several withdrawal freezes.
The One Word You Should Know in Biopharma Right Now
Before you become impressed with a particular biopharma company’s drug, you’ll want to know this detail.
7 – 10 of 240 results
